logo

Teva Pharmaceutical Industries Limited (TEVA)



Trade TEVA now with
  Date
  Headline
5/23/2018 8:00:58 AM Teva Confirms September 16 As PDUFA Date For Fremanezumab
5/15/2018 11:08:48 AM Teva Announces Publication Of Phase III Trial Data Of Fremanezumab For Preventive Treatment Of Episodic Migraine
5/3/2018 7:14:28 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 Revenue Estimate To $18.5 - $19.0 Bln From $18.3 - $18.8 Bln
5/3/2018 7:13:45 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 EPS Estimate To 2.40 - 2.65 From 2.25 - 2.50
5/3/2018 7:01:01 AM Teva Q1 GAAP EPS $1.03; Non-GAAP EPS $0.94
4/19/2018 7:01:09 AM Procter & Gamble Q3 EPS $0.95; Core EPS Up 4% To $1.00
4/19/2018 7:00:38 AM Teva And The Procter & Gamble Company Have Agreed To Terminate The PGT Healthcare Partnership
4/19/2018 12:04:02 AM P&G Acquires Consumer Health Business Of Merck KGaA, Darmstadt, Germany For Purchase Price Of About EUR 3.4 Bln
3/26/2018 2:51:50 PM Teva Announces Launch Of A Generic Version Of Lialda In U.S.
3/23/2018 1:31:19 PM Teva Announces The Launch Of A Generic Version Of ALOXI In The US
2/28/2018 9:01:02 AM Teva Launches Offering Of Senior Notes